ArticleThe Australasian journal of dermatology2026
Recurrence Rates of Incompletely Excised Primary Basal Cell Carcinoma Treated With Mohs Micrographic Surgery and Radiotherapy.
Article in The Australasian journal of dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesIncompletely excised primary basal cell carcinoma (pBCC) is a frequently encountered scenario in clinical practice, yet the significance of the phenomenon is not well described in current literature. Re-excision is recommended for high-risk incompletely excised pBCCs, but recurrence rates post re-excision of pBCCs with Mohs micrographic surgery (MMS) are not currently well documented.
methodA retrospective cohort study was undertaken, identifying patients who had undergone re-excision with MMS for pBCC prior to June 2015 from the private practices of two MMS proceduralist dermatologists' practices in Queensland, Australia. Cases required a minimum follow up of 5 years post-definitive treatment.
results141 patients were identified, with 104 ultimately being included. 31 patients did not respond, and 6 formally withdrew. 104 incompletely excised pBCCs re-excised with MMS, with some cases receiving adjuvant post-operative radiotherapy (PORT), experienced no recurrence over an average follow up period of 9.2 years. 93 (92.1%) of the 104 cases consisted of an aggressive BCC subtype, and 54 (51.9%) of the cases were in a high-risk anatomical location. Perineural invasion was present in 12 (11.5%) cases, and 6 (5.7%) of the cases received PORT.
conclusionMMS may be an effective treatment option for the management of incompletely excised pBCC in immunocompetent patients. For high-risk cases, PORT is an effective adjuvant therapy in combination with MMS. Future prospective studies with greater participant numbers and the inclusion of recurrent BCCs, as well as BCCs initially treated with non-surgical methods, may provide further insights into the role of MMS in these clinical contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.